Cargando…
Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression
OBJECTIVE: Aldo-keto reductase family 1 member B10 (AKR1B10) is a protein that is produced and secreted by a significant number of breast cancers. However, a potential confounder to the use of AKR1B10 as a tumor marker is its elevation in patients given cytotoxic chemotherapy. We therefore conducted...
Autores principales: | Robinson, Kathy, Cao, Zhe, Delfino, Kristin, Cao, Deliang, Rao, Krishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328017/ https://www.ncbi.nlm.nih.gov/pubmed/37389562 http://dx.doi.org/10.1177/03000605231179317 |
Ejemplares similares
-
Aldo-Keto Reductases in the Eye
por: Huang, Shun Ping, et al.
Publicado: (2010) -
Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice
por: Wang, Xin, et al.
Publicado: (2021) -
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis
por: Tsuzura, Hironori, et al.
Publicado: (2014) -
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
por: Huang, Li, et al.
Publicado: (2016) -
Diagnostic value of aldo‑keto reductase family 1 member B10 in human nasopharyngeal carcinoma
por: Lu, Jinping, et al.
Publicado: (2023)